Liaño Pons J, Lafita Navarro M, García Gaipo L, Colomer C, Rodriguez J, von Kriegsheim A, et al. A novel role of MNT as a negative regulator of REL and the NF-κB pathway. Oncogenesis. 2021;10:5 pubmed publisher

Mao G, Smyth S, Morris A. Regulation of PLPP3 gene expression by NF-κB family transcription factors. J Biol Chem. 2019;294:14009-14019 pubmed publisher

Kim G, Kwon H, Lee C, Verma R, Rudra D, Kim T, et al. Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness. Oncogenesis. 2018;7:91 pubmed publisher

Jennings E, Esposito D, Rittinger K, Thurston T. Structure-function analyses of the bacterial zinc metalloprotease effector protein GtgA uncover key residues required for deactivating NF-κB. J Biol Chem. 2018;293:15316-15329 pubmed publisher

Hu X, Baytak E, Li J, Akman B, Okay K, Hu G, et al. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma. Leuk Res. 2017;54:30-38 pubmed publisher

Leeman J, Weniger M, Barth T, Gilmore T. Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Oncogene. 2008;27:6770-81 pubmed publisher